Fertility and Sterility
Volume 93, Issue 7 , Pages 2285-2290, 1 May 2010

Predictors of urinary albumin excretion in women with polycystic ovary syndrome

  • Antoni J. Duleba, M.D.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of California, Davis, California
    • Corresponding Author InformationReprint requests: Antoni J. Duleba, M.D., 4869 Y Street, Suite 2500, Sacramento, CA 95817 (FAX: 916-734-6980).
  • ,
  • Ibrahim M. Ahmed, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Benha School of Medicine, Benha, Egypt

Received 31 October 2008; received in revised form 16 December 2008; accepted 26 December 2008. published online 12 February 2009.

Objective

To evaluate urinary albumin excretion (UAE) in normotensive and nondiabetic women with polycystic ovary syndrome (PCOS) in relation to their clinical, endocrine, and metabolic profiles.

Design

Observational study.

Setting

University fertility center.

Patient(s)

Sixty-three women with PCOS were evaluated.

Intervention(s)

Clinical assessments and urine and blood testing.

Main Outcome Measure(s)

Urinary albumin excretion, systolic and diastolic blood pressure, serum levels of LH, FSH, PRL, T, 17-hydroxyprogesterone, glucose, insulin, lipids, C-reactive protein, and 24-hour urinary free cortisol.

Result(s)

In univariate and multivariate correlation analysis, UAE correlated with diastolic blood pressure, insulin area under the curve during glucose tolerance test, PRL, and 17-hydroxyprogesterone. Overt microalbuminuria was detected in a significant proportion of subjects.

Conclusion(s)

Urinary albumin excretion in women with PCOS correlates well with other cardiovascular risk factors. Because the relationship between UAE and adverse cardiovascular events is continuous, evaluation of UAE in the presence of PCOS may provide clinically relevant information and may aid in selecting appropriate patients for more aggressive treatment of likely aggravating factors, such as hyperinsulinemia or borderline hypertension.

Key Words: Polycystic ovary syndrome, urinary albumin, endothelial function

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 A.J.D. has nothing to disclose. I.M.A. has nothing to disclose.

 Supported in part by grant no. RO1-HD050656 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (A.J.D.).

PII: S0015-0282(08)04834-6

doi:10.1016/j.fertnstert.2008.12.120

Fertility and Sterility
Volume 93, Issue 7 , Pages 2285-2290, 1 May 2010